Krause und Pachernegg
Verlag für Medizin und Wirtschaft
Artikel   Bilder   Volltext

Mobile Version
A-  |   A  |   A+
Werbung
 
Lunenfeld B
What Did We Learn in the Last 50 Years and what are Our Expectations for the Future of Reproductive Medicine
Journal für Reproduktionsmedizin und Endokrinologie - Journal of Reproductive Medicine and Endocrinology 2013; 10 (Sonderheft 1): 126-129

Volltext (PDF)    Übersicht   

Abb. 1: Success in ART Abb. 2: Rate of live-birth delivery per initiated cycle Abb. 3: Number of ET transferred and resulting multiple deliveries Abb. 4: Rate of OHSS per ART cycle initiated Aktuelles Bild - Abb. 5: Injection of autologous purified mitochondria
Abbildung 5: Injection of autologous purified mitochondria
Injection of autologous purified mitochondria. Oocyte stem cells are purified from the other cells, in the ovarian cortex and the mitochondria is extracted from the stem cells. In order to satisfy legal, ethical and scientific criteria the source of the mitochondrial activity must meet two requirements: the mitochondria must be obtained from the same individual as the oocyte (autologous) and the mitochondria must be germ line quality (undamaged and free of mutations).
 
Injection of autologous purified mitochondria
Vorheriges Bild Nächstes Bild  


Abbildung 5: Injection of autologous purified mitochondria
Injection of autologous purified mitochondria. Oocyte stem cells are purified from the other cells, in the ovarian cortex and the mitochondria is extracted from the stem cells. In order to satisfy legal, ethical and scientific criteria the source of the mitochondrial activity must meet two requirements: the mitochondria must be obtained from the same individual as the oocyte (autologous) and the mitochondria must be germ line quality (undamaged and free of mutations).
 
copyright © 2003–2017 Krause & Pachernegg GmbH | Sitemap | Impressum
 
Werbung